Single-arm, open-label, multicentre phase 1b/2 study to evaluate the safety and efficacy of fruquintinib combined with sintilimab and CAPEOX as a first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma (FUNCTION study): a study protocol
一项单臂、开放标签、多中心 1b/2 期研究,旨在评估呋喹替尼联合信迪利单抗和 CAPEOX 方案作为晚期胃癌或胃食管交界处腺癌一线治疗方案的安全性和有效性(FUNCTION 研究):研究方案
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2025-100241
Chen, Beibei; Zhao, Jing; Lv, Huifang; Xu, Weifeng; Wang, Jianzheng; Nie, Caiyun; He, Yunduan; Zhang, Bin; Huang, Jinxi; Liu, Yingjun; Ma, Fei; Zhang, He; Guo, Yanwei; Liu, Yudong; Li, Peng; Chen, Xiaofeng; Chen, Xiaobing